AMRN
Price
$0.40
Change
-$0.02 (-4.76%)
Updated
Apr 4, 02:28 PM (EDT)
Capitalization
357.53M
26 days until earnings call
NAGE
Price
$6.01
Change
-$0.62 (-9.35%)
Updated
Apr 4, 02:46 PM (EDT)
Capitalization
515.49M
33 days until earnings call
Ad is loading...

AMRN vs NAGE

Header iconAMRN vs NAGE Comparison
Open Charts AMRN vs NAGEBanner chart's image
Amarin
Price$0.40
Change-$0.02 (-4.76%)
Volume$100
Capitalization357.53M
Niagen Bioscience
Price$6.01
Change-$0.62 (-9.35%)
Volume$1K
Capitalization515.49M
AMRN vs NAGE Comparison Chart
Loading...
AMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NAGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMRN vs. NAGE commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRN is a Hold and NAGE is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (AMRN: $0.42 vs. NAGE: $6.63)
Brand notoriety: AMRN: Notable vs. NAGE: Not notable
AMRN represents the Pharmaceuticals: Major, while NAGE is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMRN: 104% vs. NAGE: 56%
Market capitalization -- AMRN: $357.53M vs. NAGE: $515.49M
AMRN [@Pharmaceuticals: Major] is valued at $357.53M. NAGE’s [@Biotechnology] market capitalization is $515.49M. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMRN’s FA Score shows that 0 FA rating(s) are green whileNAGE’s FA Score has 0 green FA rating(s).

  • AMRN’s FA Score: 0 green, 5 red.
  • NAGE’s FA Score: 0 green, 5 red.
According to our system of comparison, NAGE is a better buy in the long-term than AMRN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMRN’s TA Score shows that 5 TA indicator(s) are bullish while NAGE’s TA Score has 5 bullish TA indicator(s).

  • AMRN’s TA Score: 5 bullish, 5 bearish.
  • NAGE’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both AMRN and NAGE are a good buy in the short-term.

Price Growth

AMRN (@Pharmaceuticals: Major) experienced а -9.57% price change this week, while NAGE (@Biotechnology) price change was -10.28% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -3.77%. For the same industry, the average monthly price growth was -5.96%, and the average quarterly price growth was -9.79%.

The average weekly price growth across all stocks in the @Biotechnology industry was -11.29%. For the same industry, the average monthly price growth was -17.13%, and the average quarterly price growth was -18.92%.

Reported Earning Dates

AMRN is expected to report earnings on Apr 30, 2025.

NAGE is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-3.77% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

@Biotechnology (-11.29% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NAGE($515M) has a higher market cap than AMRN($358M). AMRN has higher P/E ratio than NAGE: AMRN (67.11) vs NAGE (60.27). NAGE YTD gains are higher at: 24.976 vs. AMRN (-12.866).
AMRNNAGEAMRN / NAGE
Capitalization358M515M70%
EBITDA-50.7MN/A-
Gain YTD-12.86624.976-52%
P/E Ratio67.1160.27111%
Revenue307MN/A-
Total Cash321MN/A-
Total Debt8.74MN/A-
FUNDAMENTALS RATINGS
AMRN vs NAGE: Fundamental Ratings
AMRN
NAGE
OUTLOOK RATING
1..100
789
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
82
Overvalued
PROFIT vs RISK RATING
1..100
10079
SMR RATING
1..100
9441
PRICE GROWTH RATING
1..100
8735
P/E GROWTH RATING
1..100
10098
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NAGE's Valuation (82) in the Chemicals Specialty industry is in the same range as AMRN (88) in the Pharmaceuticals Other industry. This means that NAGE’s stock grew similarly to AMRN’s over the last 12 months.

NAGE's Profit vs Risk Rating (79) in the Chemicals Specialty industry is in the same range as AMRN (100) in the Pharmaceuticals Other industry. This means that NAGE’s stock grew similarly to AMRN’s over the last 12 months.

NAGE's SMR Rating (41) in the Chemicals Specialty industry is somewhat better than the same rating for AMRN (94) in the Pharmaceuticals Other industry. This means that NAGE’s stock grew somewhat faster than AMRN’s over the last 12 months.

NAGE's Price Growth Rating (35) in the Chemicals Specialty industry is somewhat better than the same rating for AMRN (87) in the Pharmaceuticals Other industry. This means that NAGE’s stock grew somewhat faster than AMRN’s over the last 12 months.

NAGE's P/E Growth Rating (98) in the Chemicals Specialty industry is in the same range as AMRN (100) in the Pharmaceuticals Other industry. This means that NAGE’s stock grew similarly to AMRN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMRNNAGE
RSI
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
79%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 9 days ago
71%
Bullish Trend 19 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 8 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Ad is loading...
AMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NAGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
USNQX48.20N/A
N/A
Victory NASDAQ-100 Index
BMIAX7.02N/A
N/A
BNY Mellon Income Stock A
WMICX7.05N/A
N/A
Wasatch Micro Cap
EFCNX18.79N/A
N/A
Emerald Insights Investor
MXVHX6.75N/A
N/A
Empower Large Cap Value Instl

AMRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMRN has been loosely correlated with KZR. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if AMRN jumps, then KZR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMRN
1D Price
Change %
AMRN100%
-2.18%
KZR - AMRN
56%
Loosely correlated
-2.17%
CNTB - AMRN
55%
Loosely correlated
-6.44%
HRTX - AMRN
44%
Loosely correlated
-4.04%
MGNX - AMRN
44%
Loosely correlated
-5.74%
ALXO - AMRN
43%
Loosely correlated
-10.48%
More

NAGE and

Correlation & Price change

A.I.dvisor indicates that over the last year, NAGE has been loosely correlated with AXON. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if NAGE jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NAGE
1D Price
Change %
NAGE100%
-6.36%
AXON - NAGE
43%
Loosely correlated
-3.35%
EDIT - NAGE
36%
Loosely correlated
-5.08%
MDGL - NAGE
36%
Loosely correlated
-2.24%
ORMP - NAGE
35%
Loosely correlated
-1.82%
AMRN - NAGE
35%
Loosely correlated
-2.18%
More